| Description |
1 online resource (763 pages) : illustrations |
| Contents |
Front Cover; Preface; Contents; Contributors; Chapter 1: Coronary Artery Inflammation; Chapter 2: Genetic Basis of Acute Coronary Syndromes; Chapter 3: Plaque Rupture: Pathoanatomical and Biomechanical Considerations; Chapter 4: Embolization As a Pathological Mechanism; Chapter 5: Plaque Vulnerability (Insights from Intravascular Ultrasound, Optical Coherence Tomography, and Thermography); Chapter 6: Differences Between Unstable Angina and Acute Myocardial Infarction: Pathophysiological and Clinical Spectrum |
|
Chapter 7: Acute ST-Segment Elevation Myocardial Infarction: The Open Artery and Tissue ReperfusionChapter 8: Prehospital Treatment of Acute Myocardial Infarction; Chapter 9: Fibrinolysis for ST Elevation Myocardial Infarction: First and Second Generation Agents; Chapter 10: Third-Generation Fibrinolytic Agents and Combined Fibrinoplatelet Lysis for Acute Myocardial Infarction; Chapter 11: Diagnosis of Acute Coronary Syndromes in the Emergency Department: Evolution of Chest Pain Centers; Chapter 12: Facilitated Percutaneous Coronary Intervention for Acute Myocardial Infarction |
|
Chapter 13: Regional Centers of Excellence for the Care of Patients with Acute Coronary SyndromesChapter 14: The Role of Troponin in Risk Stratification; Chapter 15: B-Type Natriuretic Peptides in Acute Coronary Syndromes; Chapter 16: Inflammatory Markers in Acute Coronary Syndromes; Chapter 17: Early Invasive Vs. Early Conservative Strategies for Acute Coronary Syndromes; Chapter 18: Intravenous Platelet Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes; Chapter 19: The Role of P2Y12 Blockade in Acute Coronary Syndromes and in the Catheterization Laboratory |
|
Chapter 20: Dosing and AspirinChapter 21: Antithrombin Therapy in Acute Coronary Syndromes; Chapter 22: Bedside Anticoagulant Testing; Chapter 23: Bedside Platelet Monitoring; Chapter 24: Statins and Plaque Stabilization; Chapter 25: Diabetes in Acute Coronary Syndrome; Chapter 26: Cardiac Rupture: Pathobiology, Diagnosis, Medical Management, and Surgical Intervention; Chapter 27: Microcirculatory Dysfunction in Acute Myocardial Infarction: Evaluation, Management, and Treatment; Chapter 28: Stem Cell Therapy for ACS: The Possibility of Myocardial Regeneration |
|
Chapter 29: Cardiogenic Shock and Heart Failure Complicating Acute Myocardial InfarctionChapter 30: Treatment of Acute Myocardial Infarction: International and Regional Differences; Chapter 31: Quality of Coronary Disease Report Cards; Chapter 32: Cost-Effectiveness of New Diagnostic Tools and Therapies for Acute Coronary Syndromes; Index; A; B; C; D; E; F; G; H; I; J; L; M; N; O; P; Q; R; S; T; U; V; W |
| Summary |
Inflammation in ACS. Genetic Basis of Acute Coronary Syndromes. Plaque Rupture: Pathological and Anatomical Considerations. Embolization as a Pathological Mechanism. Plaque Vulnerability: (Insights from Intravascular Ultrasound, Optical Coherence Tomography, Thermography). Differences Between Unstable Angina and Acute Myocardial Infarction: The Pathophysiological and Clinical Spectrum. Acute ST-Segment Elevation Myocardial Infarction: The Open Artery and Tissue Reperfusion. Prehospital Treatment of Acute Myocardial Infarction. Thrombolysis for Acute Myocardial Infarction: First-and Second-Gene |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Coronary heart disease.
|
|
Biochemical markers.
|
|
Myocardial Ischemia -- therapy
|
|
Biomarkers
|
|
Myocardial Ischemia -- diagnosis
|
|
44.85 cardiology.
|
|
HEALTH & FITNESS -- Diseases -- Heart.
|
|
MEDICAL -- Cardiology.
|
|
Biochemical markers
|
|
Coronary heart disease
|
|
Infarctus du myocarde.
|
|
Fibrinolytiques.
|
|
Angina pectoris.
|
|
Hartinfarct.
|
|
Maladies coronariennes.
|
|
Myocarde -- Infarctus.
|
| Form |
Electronic book
|
| Author |
Topol, Eric J., 1954-
|
| LC no. |
2004275955 |
| ISBN |
0203025679 |
|
9780203025673 |
|
9780824757953 |
|
0824757955 |
|
9786610109845 |
|
6610109842 |
|
